MITCHELL A BARUCHIN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease JERSEY CITY, NJ NPI 1013973916

General Payments — all program years on this page

$4,557.19

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 257
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $403.44 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $403.4421

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $631.5247
2019 $750.7667
2020 $188.7413
2021 $684.3629
2022 $945.6542
2023 $952.7238
2024 $403.4421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078091408 Janssen Pharmaceuticals, Inc $15.98 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086706431 Novartis Pharmaceuticals Corporation $17.35 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086706443 Novartis Pharmaceuticals Corporation $19.02 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086706473 Novartis Pharmaceuticals Corporation $19.17 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101353224 E.R. Squibb & Sons, L.L.C. $20.12 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101353242 E.R. Squibb & Sons, L.L.C. $17.13 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101353264 E.R. Squibb & Sons, L.L.C. $20.72 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115441512 Amgen Inc. $14.62 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115441516 Amgen Inc. $16.72 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115441520 Amgen Inc. $16.10 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115441524 Amgen Inc. $14.38 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127676116 CVRx, Inc. $19.09 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131026660 PFIZER INC. $16.83 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131486263 PFIZER INC. $16.21 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141654495 Merck Sharp & Dohme LLC $15.84 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141654627 Merck Sharp & Dohme LLC $16.84 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141856186 Merck Sharp & Dohme LLC $17.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141856188 Merck Sharp & Dohme LLC $15.69 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141924149 Merck Sharp & Dohme LLC $17.93 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154168980 HEARTFLOW, INC. $60.87 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154880396 Kiniksa Pharmaceuticals International, plc $15.83 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.